Ad is loading...
ALLO
Price
$2.11
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
95 days until earnings call
ALVR
Price
$0.57
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
81 days until earnings call
Ad is loading...

ALLO vs ALVR

Header iconALLO vs ALVR Comparison
Open Charts ALLO vs ALVRBanner chart's image
Allogene Therapeutics
Price$2.11
Change-$0.00 (-0.00%)
Volume$1.9M
CapitalizationN/A
AlloVir
Price$0.57
Change-$0.00 (-0.00%)
Volume$322.44K
CapitalizationN/A
ALLO vs ALVR Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ALVR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALLO vs. ALVR commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and ALVR is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ALLO: $2.21 vs. ALVR: $0.55)
Brand notoriety: ALLO and ALVR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 65% vs. ALVR: 80%
Market capitalization -- ALLO: $463.38M vs. ALVR: $63.53M
ALLO [@Biotechnology] is valued at $463.38M. ALVR’s [@Biotechnology] market capitalization is $63.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileALVR’s FA Score has 1 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • ALVR’s FA Score: 1 green, 4 red.
According to our system of comparison, ALVR is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while ALVR’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 5 bearish.
  • ALVR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALLO and ALVR are a good buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а -2.64% price change this week, while ALVR (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

ALVR is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($463M) has a higher market cap than ALVR($63.5M). ALVR YTD gains are higher at: -19.109 vs. ALLO (-31.153). ALVR has higher annual earnings (EBITDA): -79.43M vs. ALLO (-256.67M). ALLO has more cash in the bank: 292M vs. ALVR (122M). ALVR has less debt than ALLO: ALVR (0) vs ALLO (85.1M). ALLO has higher revenues than ALVR: ALLO (43K) vs ALVR (0).
ALLOALVRALLO / ALVR
Capitalization463M63.5M729%
EBITDA-256.67M-79.43M323%
Gain YTD-31.153-19.109163%
P/E RatioN/AN/A-
Revenue43K0-
Total Cash292M122M239%
Total Debt85.1M0-
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOALVR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ALVR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFCAX40.420.58
+1.46%
Meridian Contrarian A
ONERX53.700.55
+1.03%
One Rock
DNFGX46.800.11
+0.24%
Dunham Focused Large Cap Growth N
UANQX51.840.09
+0.17%
Victory Nasdaq 100 Index Class A
GSRKX17.00N/A
N/A
Goldman Sachs International Eq Inc R

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+4.74%
FATE - ALLO
56%
Loosely correlated
+10.63%
NTLA - ALLO
55%
Loosely correlated
+3.62%
BEAM - ALLO
55%
Loosely correlated
+6.23%
CRSP - ALLO
54%
Loosely correlated
+3.43%
CRBU - ALLO
53%
Loosely correlated
+2.02%
More

ALVR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALVR has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALVR jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVR
1D Price
Change %
ALVR100%
-3.53%
MDGL - ALVR
46%
Loosely correlated
+5.53%
CRSP - ALVR
40%
Loosely correlated
+3.43%
SNDX - ALVR
39%
Loosely correlated
+3.14%
ALLO - ALVR
39%
Loosely correlated
+4.74%
XNCR - ALVR
38%
Loosely correlated
+3.78%
More